Could a Cottonseed-Derived drug help beat Chemo-Resistant colon cancer?
Disease control
Not yet recruiting
This phase 2 trial tests a combination of gossypol acetate (a drug from cottonseed), bevacizumab, and FOLFIRI chemotherapy in 20 people with metastatic colorectal cancer that has a TP53 mutation and is LRPPRC-positive. The goal is to see if this mix can shrink tumors or slow the …
Phase: PHASE2 • Sponsor: Guiying Wang • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC